Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(2):e30280.
doi: 10.1371/journal.pone.0030280. Epub 2012 Feb 7.

Alternaria-induced release of IL-18 from damaged airway epithelial cells: an NF-κB dependent mechanism of Th2 differentiation?

Affiliations

Alternaria-induced release of IL-18 from damaged airway epithelial cells: an NF-κB dependent mechanism of Th2 differentiation?

Hiroki Murai et al. PLoS One. 2012.

Abstract

Background: A series of epidemiologic studies have identified the fungus Alternaria as a major risk factor for asthma. The airway epithelium plays a critical role in the pathogenesis of allergic asthma. These reports suggest that activated airway epithelial cells can produce cytokines such as IL-25, TSLP and IL-33 that induce Th2 phenotype. However the epithelium-derived products that mediate the pro-asthma effects of Alternaria are not well characterized. We hypothesized that exposure of the airway epithelium to Alternaria releasing cytokines that can induce Th2 differentiation.

Methodology/principal finding: We used ELISA to measure human and mouse cytokines. Alternaria extract (ALT-E) induced rapid release of IL-18, but not IL-4, IL-9, IL-13, IL-25, IL-33, or TSLP from cultured normal human bronchial epithelial cells; and in the BAL fluids of naïve mice after challenge with ALT-E. Both microscopic and FACS indicated that this release was associated with necrosis of epithelial cells. ALT-E induced much greater IL-18 release compared to 19 major outdoor allergens. Culture of naïve CD4 cells with rmIL-18 induced Th2 differentiation in the absence of IL-4 and STAT6, and this effect was abrogated by disrupting NF- κB p50 or with a NEMO binding peptide inhibitor.

Conclusion/significance: Rapid and specific release of IL-18 from Alternaria-exposed damaged airway epithelial cells can directly initiate Th2 differentiation of naïve CD4(+) T-cells via a unique NF-κB dependent pathway.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Rapid release of cytokines from epithelial cells cultured with ALT-E.
(A, B) NHBE cells were cultured with PBS, ALT-E or other allergens for 15 min, and released cytokines were quantified. T. Alder, Tag Alder; S. Ragweed, Short Ragweed (n = 5 wells per treatment group). (C) BALF cytokine levels in naïve mice 60 min after challenge with 20 µg ALT-E or PBS control (n = 4 per group).
Figure 2
Figure 2. Induction of epithelial cell necrosis by ALT-E.
(A) A549 cells were cultured with ALT-E for 30 min. Changes in cell morphology were monitored by live cell imaging. (B) Time course of ALT-E-induced IL-18 release from airway epithelial cells. (C) Exposure of cultured A549 epithelial cells to ALT-E induces cell necrosis. (D) ALT-E challenge of mice induces sloughing of trypan blue positive necrotic airway epithelial cells (n = 4 per group). (E) Caspase 1 inhibitor (Cas.1 inh.) reduces IL-18 release from A549 airway epithelial cells cultured with ALT-E.
Figure 3
Figure 3. Effect of IL-18 on induction of Th2 differentiation.
(A) Effect of IL-18 on IL-4 secreting splenocytes ELISPOTS. (B) T cell differentiation protocol used in Panels 3C–E and Fig. 4. (C, D and E) Effect of IL-18 or IL-4 on Th2 differentiation of naïve CD4+ T-cells isolated from WT mice (C), IL-4−/− mice (D) and WT and STAT6−/− mice (E). n = 5−7 per group.
Figure 4
Figure 4. Effect of disruption of NF-κB p50 on Th2 differentiation of naïve CD4 T-cells treated with IL-18.
CD4+ T-cells from Wild-type (WT) and NF-κB p50−/− mice were cultured with IL-18 in the differentiation phase, restimulated with con A, and secretion of IL-4 (A), IL-5 (B) and IL-13 (C) was quantified by ELISA. n = 5−7 per group.
Figure 5
Figure 5. Effect of IL-18 on Th2 differentiation and GATA3 expression in naïve CD4+ T-cells.
(A,B,C). Effect of NEMO peptide on Th2 differentiation. Negatively selected naïve CD3+ CD4+ T-cells were cultured with plate bound anti-CD3 and anti-CD28 with PBS (PBS), IL-18 100 ng/ml (IL-18), IL-18 100 ng/ml and 10 µM NEMO Binding Domain Binding Peptide (IL-18+NEMO) for the initial culture period. The cells were washed and restimulated, and secretion of IL-4 (A), IL-5 (B) and IFN-γ(C) were quantified. The data was expressed as fold increase compared to cells cultured with PBS. (D,E,F). GATA3 expression in T-cells. Negatively selected naïve CD3+ CD4+ T-cells were cultured with plate bound anti-CD3 and anti-CD28 in the presence of PBS (D), IL-4 (E) or IL-18 (F) for 7 days. GATA3 expression was measured by flow cytometric analysis.

References

    1. WHO. World Health Organization (2007) Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach. 1st ed. World Health Organization; 2007.
    1. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363:1211–1221. - PMC - PubMed
    1. Arbes SJ, Jr, Gergen PJ, Vaughn B, Zeldin DC. Asthma cases attributable to atopy: results from the Third National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2007;120:1139–1145. - PMC - PubMed
    1. Gergen PJ, Turkeltaub PC. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976–80 (NHANES II). J Allergy Clin Immunol. 1992;90:579–588. - PubMed
    1. Nelson HS, Szefler SJ, Jacobs J, Huss K, Shapiro G, et al. The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program. J Allergy Clin Immunol. 1999;104:775–785. - PubMed

Publication types